Allscripts Hlthcare (MDRX) 13.87 $MDRX Allscripts earns

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Allscripts Hlthcare (MDRX) 13.87 $MDRX

Allscripts earns top spot in 2016 ambulatory EHR user satisfaction poll from Black Book Rankings(TM)
GlobeNewswire - Thu Jun 09, 8:36AM CDT
Allscripts (NASDAQ:MDRX) earned top scores in multiple categories and criteria for its ambulatory EHRs, including Allscripts Professional EHR, Allscripts TouchWorks EHR and Allscripts Sunrise Ambulatory Care, from research company Black Book Rankings (Black Book). The firm collected results for operational excellence from 17,973 respondents on 18 performance areas to rank more than 440 EHR providers.
MDRX: 13.87 (+0.33)

Allscripts Healthcare Solutions Set to Possibly Rebound After Yesterday's Selloff of 3.08%
Comtex SmarTrend(R) - Thu May 26, 3:06PM CDT
Allscripts Healthcare Solutions (NASDAQ:MDRX) traded in a range yesterday that spanned from a low of $12.84 to a high of $13.35. Yesterday, the shares fell 3.1%, which took the trading range below the 3-day low of $12.84 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MDRX: 13.87 (+0.33)

Allscripts (MDRX) Posts In-Line Q1 Earnings; FY16 View Up
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:01AM CDT
Allscripts Healthcare Solutions Inc. (MDRX) reported adjusted earnings of 13 cents per share in the first quarter of 2016, which surged 62.5% from the year-ago quarter.
MDSO: 48.17 (+1.14), MDRX: 13.87 (+0.33), QSII: 12.44 (+0.38), ATHN: 140.27 (+0.35)

GI Partners Closes Netsmart Technologies Transaction
PR Newswire - Tue Apr 19, 3:12PM CDT
GI Partners ("GI", a leading middle market private equity firm, announced today that it has completed the previously announced joint venture acquisition of Netsmart Technologies, Inc. ("Netsmart". GI Partners acquired Netsmart in partnership with Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX). The new joint venture is merging Allscripts' homecare software business unit with Netsmart.
MDRX: 13.87 (+0.33)

Allscripts Closes Netsmart Technologies Transaction
GlobeNewswire - Tue Apr 19, 3:10PM CDT
Allscripts Healthcare Solutions (NASDAQ:MDRX), a leader in healthcare IT solutions, today announced that it has completed the previously announced joint venture that merges the Allscripts Homecare(TM) business with Netsmart Technologies, Inc. ("Netsmart". This transaction establishes Netsmart as the largest human services and post-acute technology provider in healthcare.
MDRX: 13.87 (+0.33)

Netsmart Finalizes Home Health, Hospice and Investor Partner Transaction
Marketwired - Tue Apr 19, 3:10PM CDT
Netsmart today announced the completion of its new venture with GI Partners and Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX).
MDRX: 13.87 (+0.33)

Genstar Capital Completes Sale of Netsmart Technologies, Inc.
PR Newswire - Tue Apr 19, 3:10PM CDT
Genstar Capital, a leading middle-market private equity firm focused on investments in targeted segments of the healthcare, software, financial services, and industrial technology industries, today announced that it has completed the previously announced sale of Netsmart Technologies, Inc. to a newly-created joint venture between GI Partners and Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX).
MDRX: 13.87 (+0.33)

Research and Markets - Global Hospital Capacity Management Solutions Market CAGR Growth of 5.0% by 2025 - Trends, Technologies & Opportunities Report 2015-2025 - Key Vendors: Allscripts Healthcare Solutions, Awarepoint Corp, Cerner
PR Newswire Europe - Mon Apr 11, 6:12AM CDT
DUBLIN, April 11, 2016 /PRNewswire/ --
MDRX: 13.87 (+0.33), CERN: 60.62 (+1.01)

Allscripts to release first quarter 2016 financial results May 5
GlobeNewswire - Mon Apr 04, 6:00AM CDT
Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) will report its financial results for the three months ended March 31, 2016, after the close of regular stock market hours on Thursday, May 5, 2016. Allscripts management plans to host a conference call and webcast to discuss the company's earnings and other information at 4:30 p.m. Eastern Standard Time that same day.
MDRX: 13.87 (+0.33)

Salford Royal NHS Foundation Trust selects Allscripts population health solution to deliver integrated care
Globe Newswire - Thu Mar 31, 11:00AM CDT
First United Kingdom client to deploy dbMotionTM Solution
MDRX: 13.87 (+0.33)

Upgrade Alert for Allscripts Healthcare Solutions (MDRX)
Comtex SmarTrend(R) - Thu Mar 31, 3:21AM CDT
Allscripts Healthcare Solutions (NASDAQ:MDRX) was upgraded from Equal Weight to Overweight at Morgan Stanley today. The stock closed yesterday at $13.10 on volume of 4.9 million shares, above average daily volume of 2.7 million. Allscripts-Misys Healthcare Solutions, Inc. develops and markets clinical software. The Company's products include electronic health records, electronic prescribing, revenue cycle management, practice management, document management, medication services, hospital care management, emergency department information systems and homecare automation.
MDRX: 13.87 (+0.33)

Add Omnicell (OMCL) to Your Investment Portfolio: Here's Why
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 3:00PM CDT
On Mar 29, 2016, we issued an updated research report on Omnicell, Inc. (OMCL).
MDRX: 13.87 (+0.33), NVTA: 9.04 (+0.50), OMCL: 35.90 (+0.79), ATHN: 140.27 (+0.35)

University Hospitals significantly expands and extends relationship with Allscripts
GlobeNewswire - Tue Mar 29, 3:01PM CDT
University Hospitals (UH), in Cleveland, Ohio expanded and extended its commitment to Allscripts through 2024 to enhance patient care and improve population health management.
MDRX: 13.87 (+0.33)

Expansion Makes Netsmart the Largest Technology Company Focused Exclusively on Human Services and Post-Acute Care
Marketwired - Wed Mar 23, 7:05AM CDT
Netsmart today announced a new venture with GI Partners and Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) as investors. As a part of the venture, Netsmart will merge the Allscripts Homecare(TM) business unit into the Netsmart CareFabric® suite of solutions, enabling Homecare clients to leverage Netsmart's broad range of solutions, services, and investments in business efficiencies, clinical innovation and care coordination. Also as a new investor in Netsmart, GI Partners will provide investments and resources that will allow Netsmart to more rapidly accelerate ongoing expansion into the evolving integrated healthcare technology sector.
MDRX: 13.87 (+0.33)

Genstar Capital Announces Agreement to Sell Netsmart Technologies, Inc.
PR Newswire - Wed Mar 23, 7:04AM CDT
Genstar Capital, a leading middle-market private equity firm focused on investments in targeted segments of the healthcare, software, financial services, and industrial technology industries, today announced the signing of a definitive agreement to sell Netsmart Technologies, Inc., a leading supplier of enterprise software and software as a service (SaaS) solutions for health and human services providers, to GI Partners.
MDRX: 13.87 (+0.33)

GI Partners to Acquire Netsmart Technologies
PR Newswire - Wed Mar 23, 7:01AM CDT
GI Partners ("GI", a leading middle market private equity firm, announced today that it has signed a definitive agreement to acquire Netsmart Technologies, Inc. ("Netsmart". GI Partners is acquiring Netsmart in partnership with Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX), which will merge its Allscripts' homecare software business unit with Netsmart ("Henderson" to firmly establish Netsmart as the largest human services and post-acute technology provider in healthcare.
MDRX: 13.87 (+0.33)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 135

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 239

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 0

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 170

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 158

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 328

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 141

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Zadarma Unveils Innovative Multilingual AI Voice Assistant

Updated Category News Views 106

Introducing the Zadarma AI Voice Agent Zadarma, recognized for its exceptional VoIP services, has introduced an innovative virtual assistant - the Zadarma AI Voice Agent. This cutting-edge tool is designed to revolutionize customer interactions by providing seamless call handling, whether during traditional business hours or after hours. 24/7 Customer Support The Zadarma...

Continue Reading
Exploring Shift4 Payments Inc.'s P/E Ratio Trends and Insights

Updated Category News Views 199

Analyzing Shift4 Payments Inc. Stock Performance Shift4 Payments Inc. (NYSE: FOUR) is currently valued at $93.44, reflecting a decrease of 1.22% in today’s trading session. Despite this minor drop, there is good news: over the last month, the stock has climbed by 7.41%, and impressively, it has surged by 102.95% within the past year. This rapid appreciation has led many...

Continue Reading
SkyWest Insider Sells $2.01 Million Worth of Shares

Updated Category News Views 97

Wade J Steel Executes Major Sell Order of SkyWest Stock A significant insider transaction has come to light with Wade J Steel, Chief Commercial Officer at SkyWest (NASDAQ: SKYW), recently selling shares of the company worth $2.01 million. This transaction was documented through the latest SEC filing. Understanding the Sale The SEC filing revealed that Steel sold a total...

Continue Reading
Marpai Inc. to Discuss 2024 Financial Results in Upcoming Webcast

Updated Category News Views 140

Marpai Inc. Announces Webcast for Financial Results Marpai, Inc. is set to hold a conference call and webcast aimed at presenting vital operational and financial details surrounding its results for 2024. They are a leading technology platform company, operating as a respected Third-Party Administrator (TPA) within the health insurance sector. Marpai actively works to...

Continue Reading
Marex Group Investors Urged to Act Ahead of Critical Deadline

Updated Category News Views 160

Understanding the Legal Landscape for Marex Group Investors As an investor in Marex Group plc (NASDAQ: MRX), it's essential to stay informed and proactive regarding upcoming legal proceedings that may affect your investments. The Rosen Law Firm, a global leader in investor rights, has announced an important deadline for shareholders who purchased securities during a...

Continue Reading